Error | CodeSystem.version | Values for version differ: '2.1.0' vs '2.0.0' |
Information | CodeSystem.publisher | Values for publisher differ: 'HL7, Inc' vs 'Health Level Seven International' |
Information | CodeSystem.copyright | Values for copyright differ: 'Copyright HL7. Licensed under creative commons public domain' vs 'This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license' |
Name | Value | Comments | |
---|---|---|---|
caseSensitive | true | ||
compositional | false | ||
content | complete | ||
copyright | Copyright HL7. Licensed under creative commons public domain | This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license |
|
date | 2019-12-01 | ||
description | HL7-defined code system of concepts that describes the status of product evaluation. Used in HL7 Version 2.x messaging in the PCR segment. | ||
experimental | false | ||
hierarchyMeaning | is-a | ||
jurisdiction | |||
name | StatusOfEvaluation | ||
publisher | HL7, Inc | Health Level Seven International |
|
purpose | Underlying Master Code System for V2 table 0247 (Status of Evaluation) | ||
status | active | ||
title | statusOfEvaluation | ||
url | http://terminology.hl7.org/CodeSystem/v2-0247 | ||
version | 2.1.0 | 2.0.0 |
|
versionNeeded | false |
Code | Display | status | deprecated | status | deprecated | Comments | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Y | Evaluation completed | A | A | A | A | ||||||
P | Evaluation in progress | A | A | A | A | ||||||
K | Problem already known, no evaluation necessary | A | A | A | A | ||||||
X | Product not made by company | A | A | A | A | ||||||
A | Evaluation anticipated, but not yet begun | A | A | A | A | ||||||
D | Product discarded -- unable to follow up | A | A | A | A | ||||||
C | Product received in condition which made analysis impossible | A | A | A | A | ||||||
I | Product remains implanted -- unable to follow up | A | A | A | A | ||||||
U | Product unavailable for follow up investigation | A | A | A | A | ||||||
Q | Product under quarantine -- unable to follow up | A | A | A | A | ||||||
R | Product under recall/corrective action | A | A | A | A | ||||||
O | Other | A | A | A | A |